Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.3.4 and no longer lists Revision: v3.3.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now includes a Locations section listing the study sites by state (Alabama, California, Florida, Georgia, Minnesota, Missouri, North Carolina, Texas).SummaryDifference0.8%

- Check54 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not be about the study. The revision/version information has been updated to v3.3.2 (from v3.2.0).SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding lapse notice banner from the page; this administrative update does not affect the study details or user actions — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedThere are no significant additions or deletions on the Study Details page for NCT03945981; the content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check104 days agoChange DetectedCore status messaging updated and version bumped from v3.1.0 to v3.2.0; emphasizes funding-related operational status for NIH Clinical Center.SummaryDifference2%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.